Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001209191-17-009965
Filing Date
2017-02-13
Accepted
2017-02-13 16:13:46
Documents
1
Effectiveness Date
2017-02-13
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8636
  Complete submission text file 0001209191-17-009965.txt   9642
Mailing Address 1712 HUMBOLT AVENUE SOUTH MINNEAPOLIS MN 55403
Business Address 1712 HUMBOLT AVENUE SOUTH MINNEAPOLIS MN 55403 612-805-9054
Gila Therapeutics, Inc. (Filer) CIK: 0001673503 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-280594 | Film No.: 17599257